IDENTIFICATION AND CHARACTERIZATION OF A NOVEL MATRIX-DEGRADING PROTEASE FROM HORMONE-DEPENDENT HUMAN BREAST-CANCER CELLS

被引:2
|
作者
SHI, YE
TORRI, J
YIEH, L
WELLSTEIN, A
LIPPMAN, ME
DICKSON, RB
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A novel matrix-degrading enzyme was identified from human breast cancer cells. This enzyme appears as major gelatinase in hormone-dependent breast cancer cell lines and has as an apparent molecular mass of 80 kDa on gelatin zymography. The 80-kDa enzyme has a unique metal ion specificity. In addition to calcium ions, the gelatinolytic activity can be supported by manganese and/or magnesium. Unlike 92- and 72-kDa gelatinases and other known members of the metalloproteinase family, the 80-kDa protease is not activated by p-aminophenylmercuric acetate and its gelatinolytic activity is not inhibited by tissue inhibitor of metalloproteinase 2. It is active over the pH range 7.5-9.5 with an optimum at pH 8.5. The enzyme degrades gelatin and type IV collagen. The proteolytic activity of the enzyme is inhibited by EDTA and leupeptin. These unique features clearly distinguish the 80-kDa protease from the known 92-and 72-kDa gelatinases. The expression of 80-kDa enzyme can be detected in hormone-dependent human breast cancer cell lines in vitro and in tumors grown from these cells in athymic nude mice.
引用
收藏
页码:1409 / 1415
页数:7
相关论文
共 50 条
  • [31] Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines
    Spencer, VA
    Samuel, SK
    Davie, JR
    CANCER RESEARCH, 2000, 60 (02) : 288 - 292
  • [32] Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
    Scherbakov, Alexander M.
    Komkov, Alexander V.
    Komendantova, Anna S.
    Yastrebova, Margarita A.
    Andreeva, Olga E.
    Shirinian, Valerii Z.
    Hajra, Alakananda
    Zavarzin, Igor V.
    Volkova, Yulia A.
    FRONTIERS IN PHARMACOLOGY, 2018, 8
  • [33] JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells
    Nedret Altiok
    Meral Koyuturk
    Soner Altiok
    Breast Cancer Research and Treatment, 2007, 105 : 247 - 254
  • [34] Biochemical evaluation of extracts from Caralluma tuberculata against hormone-dependent breast cancer cells
    Ahmed, S.
    Owen, C. P.
    Waheed, A.
    Nisa, S.
    Bibi, Y.
    Chaudhary, M. Fayyaz
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A135 - A135
  • [35] JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells
    Altiok, Nedret
    Koyuturk, Meral
    Altiok, Soner
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (03) : 247 - 254
  • [36] HORMONE DEPENDENT HUMAN BREAST-CANCER IN TISSUE-CULTURE
    LIPPMAN, M
    CLINICAL RESEARCH, 1975, 23 (03): : A425 - A425
  • [37] DIFFERENTIAL REGULATION OF AP1 ACTIVITY BY RETINOIC ACID IN HORMONE-DEPENDENT AND-INDEPENDENT BREAST-CANCER CELLS
    VANDERBURG, B
    SLAGERDAVIDOV, R
    VANDERLEEDE, BJM
    DELAAT, SW
    VANDERSAAG, PT
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 112 (02) : 143 - 152
  • [38] Chromatin remodeling in hormone-dependent and independent human breast cancer cell lines
    Chailleux, C
    Giamarchi, C
    Morales, V
    Moro, F
    Richard-Foy, H
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (02) : 130 - 135
  • [39] Effects of capsicodendrin in MCF-7 hormone-dependent breast cancer cells
    Munoz Acuna, U.
    Rakotondraibe, L. H.
    Carcache de Blanco, E. J.
    PLANTA MEDICA, 2014, 80 (10) : 796 - 796
  • [40] Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells
    Yue, Wei
    Fan, Ping
    Wang, Jiping
    Li, Yuebai
    Santen, Richard J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 106 (1-5): : 102 - 110